Diabetes Medicine Pulled Over Carcinogen Concerns

Sun's Riomet ER is the ninth brand recalled since May
By Bob Cronin,  Newser Staff
Posted Sep 24, 2020 6:00 PM CDT
Diabetes Medicine Pulled Over Carcinogen Concerns
A label for the drug metformin. Sun Pharma has pulled its lot No. AB06381.   (FDA via AP)

(Newser) – The Food and Drug Administration has posted the voluntary recall of another metformin—the ninth brand pulled since May. Riomet ER, a Type 2 diabetes medicine marketed by Sun Pharmaceutical, was found in tests to contain too much N-nitrosodimethylamine, a carcinogen, the Miami Herald reports. The recall applies to Lot AB06381: 500mg tablets of metformin hydrochloride labeled for extended-release oral suspension, with an expiration date of October 2021. The FDA posts a roundup of its NDMA announcements here. (NDMA also was a concern when retail chains dropped Zantac last year.)

We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.
Get the news faster.
Tap to install our app.
X
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.

X